• Promote the research carried out in the area of novel drugs in the Universidad de Navarra, and collaborate with other companies and institutions in benefit of the person who suffers, being receiver and ultimate link of the novel drug activity chain.
• To take into consideration, in all CIFA activities, the R&D&I of Novel Drugs, from the early beginnings of the design and synthesis of compounds to the preclinical biological evaluation, including clinical trials, when necessary.
• To educate and train young professionals in the study of novel drugs, covering all the phases of development that lead to innovation.
• To take into consideration, in all CIFA activities, the R&D&I of Novel Drugs, from the early beginnings of the design and synthesis of compounds to the preclinical biological evaluation, including clinical trials, when necessary.
• To educate and train young professionals in the study of novel drugs, covering all the phases of development that lead to innovation.
